The Cancer Target Discovery and Development network (CTD2) is a project of the Office of Cancer Genetics in the National Cancer Institute (one of the National Institutes of Health). Using various methodologies, The thirteen research centers that comprise the network are working together to extend the list of potential molecular targets and approaches for treating cancer beyond the recurrently mutated genes identified by genetic mapping projects.
As part of their ongoing activities, the researchers are collecting some of their robust results in an explorable data base called the Dashboard, which allows internal and external users to explore the connections that link various genes, biomarkers, drugs, diseases, and other entitities. To help frame some of these connections, the Dashboard features accessible summaries of the results and their significance, which is what I have been writing. Currently these stories are only accessible in their collected form on the Dashboard website at
CTD2 Dashboard Stories